Sector
Cell & Gene Therapy Executive Search & Recruitment
Cell and gene therapy is transitioning from clinical proof-of-concept to industrial-scale delivery. The bottlenecks are no longer scientific. They are operational: viral vector manufacturing yields, autologous supply chain logistics, vein-to-vein coordination, and a workforce trained in GMP-grade cell processing at commercial scale. ProGen Search is a specialist cell and gene therapy executive search firm placing the senior leaders who navigate this transition, from VP-level manufacturing hires to site heads commissioning new GMP viral vector and cell therapy facilities.
Coverage
What Our CGT Recruitment Covers
Executive search and market intelligence across autologous and allogeneic cell therapy manufacturing, viral vector production (AAV, lentivirus), gene editing platforms (CRISPR, base editing), GMP facility design and commissioning, quality systems for advanced therapy medicinal products (ATMPs), regulatory strategy (FDA, EMA), and commercial supply chain architecture for cell and gene therapies.
Leadership
Cell & Gene Therapy Leadership Roles We Place
Track Record
Related Mandates
CGT CDMO (Europe)
Chief Commercial Officer
Tripled qualified opportunity pipeline in CGT market
CGT CDMO (Europe)
Multi-Hire Commercial Buildout
Hired five commercial leaders across EU markets
Gene Editing Biotech (Europe)
Chief Scientific Officer
Advanced platform from discovery to preclinical readiness
If you are hiring senior leadership in cell or gene therapy, book a confidential call to discuss your requirements.
Book a Confidential Call